Previous Article | Next Article 
Journal of Clinical Microbiology, December 2001, p. 4407-4412, Vol. 39, No. 12
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.12.4407-4412.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
European Proficiency Testing Program for Molecular
Detection and Quantitation of Hepatitis B Virus DNA
Elizabeth
Valentine-Thon,1,*
Anton M.
van Loon,2
Jurjen
Schirm,3
Jim
Reid,4
Paul E.
Klapper,5 and
Graham M.
Cleator5
Department of Molecular Biology, Laboratory
Dr. Schiwara and Partners, 28357 Bremen,
Germany1; Department of Virology,
University Medical Center Utrecht, Utrecht,2 and
Department of Virology, Regional Public Health Laboratory,
Groningen,3 The Netherlands; and Shield
Diagnostics Limited, Dundee,4 and
Department of Virology, Manchester Royal Infirmary,
Manchester,5 United Kingdom
Received 30 April 2001/Returned for modification 14 August
2001/Accepted 27 September 2001
External quality control of hepatitis B virus (HBV) DNA detection
remains an important issue. This study reports and compares the results
obtained from two different proficiency panels for both the qualitative
and quantitative assessment of HBV DNA. The panels were designed by the
European Union Quality Control Concerted Action, prepared by Boston
Biomedica, Inc., and distributed in May 1999 (panel 1) and February
2000 (panel 2). Each contained two negative samples and six positive
samples with 103 to 107 copies/ml (panel 1) or
103 to 2 × 106 copies of HBV DNA per ml
(panel 2). For panel 1, 42 laboratories submitted 20 qualitative (all
in-house PCRs) and 37 quantitative (87% commercial assays) data sets.
For panel 2, 51 laboratories submitted 25 qualitative (all in-house
PCRs) and 47 quantitative (94% commercial assays) data sets. Five data
sets (8.8%) in panel 1 and two data sets (2.8%) in panel 2 contained
totals of six and two false-positives, respectively, corresponding to
false-positive result rates of 5.3% for panel 1 and 1.4% for panel 2. The false-negative result rates of 10.5% for panel 1 and 17.4% for
panel 2 were dependent on the detection levels of the assays employed
as well as panel composition. In the qualitative analysis of all data
sets, 47.4% (panel 1) and 51.4% (panel 2) had all samples correct. An
adequate or better score (all correct or only the weak-positive sample missed) was obtained with 77.2% of the panel 1 samples and 68.1% of
the panel 2 samples. In the quantitative analysis, 57.1% (panel 1) and
42.6% (panel 2) of the data sets achieved an adequate or better score
(positive results within the acceptable range of the geometric
mean ± 0.5 log10 of all positive results). These results demonstrate that while the qualitative performance of HBV
detection has considerably improved compared to that of a previously
published HBV proficiency study, the detection levels of many
commercial quantitative assays are still too high to allow adequate
quantitation of all relevant clinical samples.
*
Corresponding author. Mailing address: Department of
Molecular Biology, Laboratory Dr. Schiwara and Partners, Haferwende 12, 28357 Bremen, Germany. Phone: 0049-421-20720. Fax: 0049-421-2072-167. E-mail: Elizabeth.Valentine-Thon{at}Schiwara.de.
Journal of Clinical Microbiology, December 2001, p. 4407-4412, Vol. 39, No. 12
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.12.4407-4412.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Loth, L., Prijono, W. B., Wibawa, H., Usman, T. B.
(2008). Evaluation of two avian influenza type A rapid antigen tests under Indonesian field conditions. jvdi
20: 642-644
[Abstract]
[Full Text]
-
Niedrig, M., Meyer, H., Panning, M., Drosten, C.
(2006). Follow-Up on Diagnostic Proficiency of Laboratories Equipped To Perform Orthopoxvirus Detection and Quantification by PCR: the Second International External Quality Assurance Study. J. Clin. Microbiol.
44: 1283-1287
[Abstract]
[Full Text]
-
Patton, S. J., Wallace, A. J., Elles, R.
(2006). Benchmark for Evaluating the Quality of DNA Sequencing: Proposal from an International External Quality Assessment Scheme. Clin. Chem.
52: 728-736
[Abstract]
[Full Text]
-
Loens, K., Beck, T., Ursi, D., Pattyn, S., Goossens, H., Ieven, M.
(2006). Two Quality Control Exercises Involving Nucleic Acid Amplification Methods for Detection of Mycoplasma pneumoniae and Chlamydophila pneumoniae and Carried Out 2 Years Apart (in 2002 and 2004).. J. Clin. Microbiol.
44: 899-908
[Abstract]
[Full Text]
-
Quint, W. G. V., Pagliusi, S. R., Lelie, N., de Villiers, E.-M., Wheeler, C. M., the World Health Organization Human Papillomavirus,
(2006). Results of the First World Health Organization International Collaborative Study of Detection of Human Papillomavirus DNA. J. Clin. Microbiol.
44: 571-579
[Abstract]
[Full Text]
-
Muyldermans, G., Soetens, O., Antoine, M., Bruisten, S., Vincart, B., Doucet-Populaire, F., Fry, N. K., Olcen, P., Scheftel, J. M., Senterre, J. M., van der Zee, A., Riffelmann, M., Pierard, D., Lauwers, S.
(2005). External Quality Assessment for Molecular Detection of Bordetella pertussis in European Laboratories. J. Clin. Microbiol.
43: 30-35
[Abstract]
[Full Text]
-
Shyamala, V., Arcangel, P., Cottrell, J., Coit, D., Medina-Selby, A., McCoin, C., Madriaga, D., Chien, D., Phelps, B.
(2004). Assessment of the Target-Capture PCR Hepatitis B Virus (HBV) DNA Quantitative Assay and Comparison with Commercial HBV DNA Quantitative Assays. J. Clin. Microbiol.
42: 5199-5204
[Abstract]
[Full Text]
-
Keilholz, U., Goldin-Lang, P., Bechrakis, N. E., Max, N., Letsch, A., Schmittel, A., Scheibenbogen, C., Heufelder, K., Eggermont, A., Thiel, E.
(2004). Quantitative Detection of Circulating Tumor Cells in Cutaneous and Ocular Melanoma and Quality Assessment by Real-Time Reverse Transcriptase-Polymerase Chain Reaction. Clin. Cancer Res.
10: 1605-1612
[Abstract]
[Full Text]
-
Leb, V., Stocher, M., Valentine-Thon, E., Holzl, G., Kessler, H., Stekel, H., Berg, J.
(2004). Fully Automated, Internally Controlled Quantification of Hepatitis B Virus DNA by Real-Time PCR by Use of the MagNA Pure LC and LightCycler Instruments. J. Clin. Microbiol.
42: 585-590
[Abstract]
[Full Text]
-
Verkooyen, R. P., Noordhoek, G. T., Klapper, P. E., Reid, J., Schirm, J., Cleator, G. M., Ieven, M., Hoddevik, G.
(2003). Reliability of Nucleic Acid Amplification Methods for Detection of Chlamydia trachomatis in Urine: Results of the First International Collaborative Quality Control Study among 96 Laboratories. J. Clin. Microbiol.
41: 3013-3016
[Abstract]
[Full Text]
-
Raggi, C. C., Pinzani, P., Paradiso, A., Pazzagli, M., Orlando, C.
(2003). External Quality Assurance Program for PCR Amplification of Genomic DNA: An Italian Experience. Clin. Chem.
49: 782-791
[Abstract]
[Full Text]
-
Schirm, J., van Loon, A. M., Valentine-Thon, E., Klapper, P. E., Reid, J., Cleator, G. M.
(2002). External Quality Assessment Program for Qualitative and Quantitative Detection of Hepatitis C Virus RNA in Diagnostic Virology. J. Clin. Microbiol.
40: 2973-2980
[Abstract]
[Full Text]
-
Berger, A., Preiser, W.
(2002). Viral genome quantification as a tool for improving patient management: the example of HIV, HBV, HCV and CMV. J Antimicrob Chemother
49: 713-721
[Abstract]
[Full Text]